Alan Lin

Consumer Health Corporate strategic planning & PMO: Short- & long-term strategic planning & innovation – macro/industrial rationale, competitor/consumer analysis, internal business & process overhaul, key growth strategies & new portfolio/channel launch design (e.g., Centrum Meta-health Daily Nutrition Customization etc.) Corporate business planning & reporting: Annual performance targeting, monitor & business reporting - by BU, category, brand & channels; Corporate & BU pricing, P/L management & external competitor benchmark (e.g., detailed competitor value chain & P/L assessment by category, sub-category & channels etc.); Corporate & BU sales, promotion & profitability management etc. Growth innovation & transformation: Design, align & deliver BD innovation/investment strategies (e.g., Cross Border Strategy & Innovation, NPD assessment, Lifecycle Analysis, Innovation Model, etc.) & digital transformation tasks (e.g., DBPI, BPS, SIPAC KOL/Expert etc.). Also driven deep human understanding (DHU) strategic growth planning (e.g., China Future Silver/Holistic Health Foresight Development, Repeatable Growth Model Integration etc.)

Corporate strategic planning & PMO: Short- & long-term strategic planning & innovation – macro/industrial rationale, competitor/consumer analysis, internal business & process overhaul, key growth strategies & new portfolio/channel launch design (e.g., remote medical & skincare diagnosis) Corporate business planning & reporting: Annual performance targeting, monitor & business reporting - by BU, category, brand & channels; Corporate & BU pricing, P/L management & external competitor benchmark (e.g., detailed competitor value chain & P/L assessment by category, sub-category & channels etc.); Corporate & BU sales, promotion & profitability management; Cross border promotion policy setting & alignment w/ HQ etc. Growth innovation & new BD: Ali TMIC C2M NPD implementation (Pricing, Promotion management, Regulatory assessment, A&P allocation & overall P/L forecasting/alignment etc.)

New business development: Pricing, Promotion management, Regulatory assessment, A&P allocation & overall P/L forecasting/alignment etc. [Leading Case: LA ROCHE-POSAY CICAPLAST, Annual sales: RMB 200M/ Net PM: 15%; SKINCEUTICALS PHYTO CORRECTIVE, Annual sales: 230M/Net PM: 18%] Strategic planning: Short- & long-term strategic planning & innovation – macro/industrial rationale, competitor/consumer analysis, internal business & process overhaul, key growth strategies & new portfolio/channel launch design (e.g., CBEC business planning & development.)

Project manager: responsible in strategic planning and business development for launching new products into Chinese market, in the terms of industrial/regulatory research, marketing/distribution/sales analysis, competitor/customer assessment, development of new business models & compiling of strategic investing solutions (major clients: Fortune 500 Healthcare & FMCG) Project manager: responsible in strategic planning for M&A in Chinese market, in the terms of industrial/marketing research, financial/strategic valuation, due diligence report, company life cycle assessment and development of new product investing strategies (major clients: Fortune 500 Healthcare & FMCG)

Core project member, participated in the £ 1.4m pharmaceutical investing program, timely reported to clients about their investing states and maintained long-term/stable investor relationships. On the basis of quantitative modelling, conducted portfolio analysis, whilst instantaneously tracked the market trends and designed various effectual investing solutions. Benefitted by the chemical background, optimized fund allocations of individual portfolios and created improved investing returns.